Nutex Health
- Market cap
- 1.46B
- P/E (TTM)i
- 8.26
- P/Bi
- 3.70
- EPSi
- 10.48
- Div yieldi
- 0.00%
- 52W posi
- 91%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 44.17% -0.31pp
- Institutions
- 183
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-05-28
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 39 buys · 11 sells
| Name | Role | Stake |
|---|---|---|
| Thomas Vo | Chairperson & CEO | 30.71% |
| Michael Chang | Chief Medical Officer | 1.20% |
| Kelvin Spears | Director | 0.51% |
| Jon Bates | Chief Financial Officer | 0.12% |
| Warren Hosseinion | President | 0.11% |
| Joshua DeTillio | Chief Operating Officer | 0.10% |
| Pamela Montgomery | Chief Legal Officer of Healthcare & Board Secretary | 0.04% |
| Elisa Luqman | Chief Legal Officer (SEC) & Board Secretary | 0.03% |
| Frank Jaumot | Independent Director | 0.01% |
| Cheryl Grenas | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-17 | Scott Saunders | Director | Open Market Disposition | -203 | $214.25 |
| 2026-07-30 | Scott Saunders | Director | Derivative Exercise and Retained | +603 | -- |
| 2026-07-30 | Frank Jaumot | Independent Director | Derivative Exercise and Retained | +603 | -- |
| 2026-07-30 | Michael Reed | -- | Derivative Exercise and Retained | +603 | -- |
| 2026-07-30 | Cheryl Grenas | Independent Director | Derivative Exercise and Retained | +603 | -- |
| 2026-06-03 | Kelvin Spears | Director | Private Acquisition | +2,519 | -- |
| 2026-05-27 | Thomas Vo | Chairperson & CEO | Private Acquisition | +75,747 | -- |
| 2026-04-22 | Scott Saunders | Director | Other Derivative Acquisition | +823 | -- |
| 2026-04-22 | Frank Jaumot | Independent Director | Other Derivative Acquisition | +823 | -- |
| 2026-04-22 | Michael Reed | -- | Other Derivative Acquisition | +823 | -- |
| 2026-04-22 | Cheryl Grenas | Independent Director | Other Derivative Acquisition | +823 | -- |
| 2026-04-08 | Thomas Vo | Chairperson & CEO | Private Acquisition | +184,071 | -- |
| 2026-03-19 | Frank Jaumot | Independent Director | Open Market Acquisition | +150 | $93.56 |
| 2026-03-18 | Warren Hosseinion | President | Open Market Acquisition | +252 | $94.07 |
| 2026-03-16 | Kelvin Spears | Director | Open Market Acquisition | +10 | $94.46 |
| 2026-03-12 | Pamela Montgomery | Chief Legal Officer of Healthcare & Board Secretary | Open Market Acquisition | +79 | $88.87 |
| 2026-03-10 | Jon Bates | Chief Financial Officer | Other Derivative Acquisition | +1,694 | -- |
| 2026-03-10 | Wesley Bamburg | Chief Operating Officer | Other Derivative Acquisition | +2,411 | -- |
| 2026-03-09 | Jon Bates | Chief Financial Officer | Derivative Exercise and Retained | +2,667 | -- |
| 2026-03-09 | Warren Hosseinion | President | Derivative Exercise and Sale | -3,274 | $86.22 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:32:22 · For reference only, not investment advice and not tailored to your situation.